Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
41
TMDX Quote, Financials, Valuation and Earnings
Last price:
$107.35
Seasonality move
:
38.93%
Day range:
$102.97 - $108.73
52-week range:
$62.23 - $156.00
Dividend yield:
0%
P/E ratio:
22.45x
P/S ratio:
7.30x
P/B ratio:
7.91x
Volume:
695.7K
Avg. volume:
1.1M
1-year change:
54.87%
Market cap:
$3.7B
Revenue:
$605.5M
EPS (TTM):
$4.86
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$174M | $0.61 | 20.21% | -18.83% | $156.10 |
|
CNMD
CONMED Corp.
|
$310.6M | $0.82 | -2.76% | 322.31% | $44.20 |
|
ELMD
Electromed, Inc.
|
$17.5M | -- | 11.79% | -- | $37.00 |
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$11.9M | -$0.07 | 0.12% | -30.56% | $2.75 |
|
STXS
Stereotaxis, Inc.
|
$8.6M | -$0.05 | 6.62% | -28.47% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$104.80 | $156.10 | $3.7B | 22.45x | $0.00 | 0% | 7.30x |
|
CNMD
CONMED Corp.
|
$34.08 | $44.20 | $1B | 22.49x | $0.20 | 2.4% | 0.77x |
|
ELMD
Electromed, Inc.
|
$23.61 | $37.00 | $198.3M | 23.32x | $0.00 | 0% | 3.05x |
|
ESMC
Escalon Medical Corp.
|
$0.16 | -- | $1.1M | 154.45x | $0.00 | 0% | 0.14x |
|
IRIX
IRIDEX Corp.
|
$1.00 | $2.75 | $17.8M | -- | $0.00 | 0% | 0.33x |
|
STXS
Stereotaxis, Inc.
|
$1.88 | $4.20 | $184.3M | -- | $0.00 | 0% | 5.32x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
52.33% | 3.305 | 12.46% | 6.41x |
|
CNMD
CONMED Corp.
|
46.21% | 1.725 | 70.58% | 0.94x |
|
ELMD
Electromed, Inc.
|
-- | 0.121 | -- | 4.40x |
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.970 | 43.39% | 1.03x |
|
IRIX
IRIDEX Corp.
|
47.94% | 0.152 | 17.71% | 1.18x |
|
STXS
Stereotaxis, Inc.
|
22.5% | 1.644 | 2.42% | 0.89x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$93.4M | $21.3M | 22.46% | 57.97% | 13.23% | $19M |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
IRIX
IRIDEX Corp.
|
$5.5M | -$15K | -45.33% | -119.2% | -0.1% | -$1.2M |
|
STXS
Stereotaxis, Inc.
|
$4.3M | -$5.3M | -126.96% | -191.14% | -60.85% | -$4M |
TransMedics Group, Inc. vs. Competitors
-
Which has Higher Returns TMDX or CNMD?
CONMED Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 4.48%. TransMedics Group, Inc.'s return on equity of 57.97% beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About TMDX or CNMD?
TransMedics Group, Inc. has a consensus price target of $156.10, signalling upside risk potential of 53.91%. On the other hand CONMED Corp. has an analysts' consensus of $44.20 which suggests that it could grow by 29.7%. Given that TransMedics Group, Inc. has higher upside potential than CONMED Corp., analysts believe TransMedics Group, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 2 0 CNMDCONMED Corp.0 6 0 -
Is TMDX or CNMD More Risky?
TransMedics Group, Inc. has a beta of 2.094, which suggesting that the stock is 109.434% more volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.986, suggesting its less volatile than the S&P 500 by 1.399%.
-
Which is a Better Dividend Stock TMDX or CNMD?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 2.4% to investors and pays a quarterly dividend of $0.20 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TMDX or CNMD?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are smaller than CONMED Corp. quarterly revenues of $373.5M. TransMedics Group, Inc.'s net income of $105.4M is higher than CONMED Corp.'s net income of $16.7M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 22.45x while CONMED Corp.'s PE ratio is 22.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 7.30x versus 0.77x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.7.30x 22.45x $160.8M $105.4M CNMDCONMED Corp.0.77x 22.49x $373.5M $16.7M
-
Which has Higher Returns TMDX or ELMD?
Electromed, Inc. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 14.61%. TransMedics Group, Inc.'s return on equity of 57.97% beat Electromed, Inc.'s return on equity of 20.35%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M ELMDElectromed, Inc.78.42% $0.32 $45.4M -
What do Analysts Say About TMDX or ELMD?
TransMedics Group, Inc. has a consensus price target of $156.10, signalling upside risk potential of 53.91%. On the other hand Electromed, Inc. has an analysts' consensus of $37.00 which suggests that it could grow by 56.71%. Given that Electromed, Inc. has higher upside potential than TransMedics Group, Inc., analysts believe Electromed, Inc. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 2 0 ELMDElectromed, Inc.3 0 0 -
Is TMDX or ELMD More Risky?
TransMedics Group, Inc. has a beta of 2.094, which suggesting that the stock is 109.434% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.317, suggesting its less volatile than the S&P 500 by 68.266%.
-
Which is a Better Dividend Stock TMDX or ELMD?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or ELMD?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than Electromed, Inc. quarterly revenues of $18.9M. TransMedics Group, Inc.'s net income of $105.4M is higher than Electromed, Inc.'s net income of $2.8M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 22.45x while Electromed, Inc.'s PE ratio is 23.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 7.30x versus 3.05x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.7.30x 22.45x $160.8M $105.4M ELMDElectromed, Inc.3.05x 23.32x $18.9M $2.8M
-
Which has Higher Returns TMDX or ESMC?
Escalon Medical Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 2.72%. TransMedics Group, Inc.'s return on equity of 57.97% beat Escalon Medical Corp.'s return on equity of -12.94%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M ESMCEscalon Medical Corp.43.33% $0.01 $2.6M -
What do Analysts Say About TMDX or ESMC?
TransMedics Group, Inc. has a consensus price target of $156.10, signalling upside risk potential of 53.91%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 7641.94%. Given that Escalon Medical Corp. has higher upside potential than TransMedics Group, Inc., analysts believe Escalon Medical Corp. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 2 0 ESMCEscalon Medical Corp.0 0 0 -
Is TMDX or ESMC More Risky?
TransMedics Group, Inc. has a beta of 2.094, which suggesting that the stock is 109.434% more volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.181, suggesting its less volatile than the S&P 500 by 81.879%.
-
Which is a Better Dividend Stock TMDX or ESMC?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or ESMC?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than Escalon Medical Corp. quarterly revenues of $3.6M. TransMedics Group, Inc.'s net income of $105.4M is higher than Escalon Medical Corp.'s net income of $97.7K. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 22.45x while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 7.30x versus 0.14x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.7.30x 22.45x $160.8M $105.4M ESMCEscalon Medical Corp.0.14x 154.45x $3.6M $97.7K
-
Which has Higher Returns TMDX or IRIX?
IRIDEX Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of -1.25%. TransMedics Group, Inc.'s return on equity of 57.97% beat IRIDEX Corp.'s return on equity of -119.2%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M IRIXIRIDEX Corp.37.2% -$0.01 $9.5M -
What do Analysts Say About TMDX or IRIX?
TransMedics Group, Inc. has a consensus price target of $156.10, signalling upside risk potential of 53.91%. On the other hand IRIDEX Corp. has an analysts' consensus of $2.75 which suggests that it could grow by 175.94%. Given that IRIDEX Corp. has higher upside potential than TransMedics Group, Inc., analysts believe IRIDEX Corp. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 2 0 IRIXIRIDEX Corp.1 0 0 -
Is TMDX or IRIX More Risky?
TransMedics Group, Inc. has a beta of 2.094, which suggesting that the stock is 109.434% more volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.753, suggesting its less volatile than the S&P 500 by 24.713%.
-
Which is a Better Dividend Stock TMDX or IRIX?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or IRIX?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than IRIDEX Corp. quarterly revenues of $14.7M. TransMedics Group, Inc.'s net income of $105.4M is higher than IRIDEX Corp.'s net income of -$184K. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 22.45x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 7.30x versus 0.33x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.7.30x 22.45x $160.8M $105.4M IRIXIRIDEX Corp.0.33x -- $14.7M -$184K
-
Which has Higher Returns TMDX or STXS?
Stereotaxis, Inc. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of -64%. TransMedics Group, Inc.'s return on equity of 57.97% beat Stereotaxis, Inc.'s return on equity of -191.14%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M STXSStereotaxis, Inc.50.07% -$0.06 $24.2M -
What do Analysts Say About TMDX or STXS?
TransMedics Group, Inc. has a consensus price target of $156.10, signalling upside risk potential of 53.91%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 123.4%. Given that Stereotaxis, Inc. has higher upside potential than TransMedics Group, Inc., analysts believe Stereotaxis, Inc. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 2 0 STXSStereotaxis, Inc.3 0 0 -
Is TMDX or STXS More Risky?
TransMedics Group, Inc. has a beta of 2.094, which suggesting that the stock is 109.434% more volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.428, suggesting its more volatile than the S&P 500 by 42.77%.
-
Which is a Better Dividend Stock TMDX or STXS?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or STXS?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than Stereotaxis, Inc. quarterly revenues of $8.6M. TransMedics Group, Inc.'s net income of $105.4M is higher than Stereotaxis, Inc.'s net income of -$5.5M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 22.45x while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 7.30x versus 5.32x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.7.30x 22.45x $160.8M $105.4M STXSStereotaxis, Inc.5.32x -- $8.6M -$5.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
42
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Sell
50
Is GOOG Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 28x
Alerts
Buy
83
SLNO alert for Apr 7
Soleno Therapeutics, Inc. [SLNO] is up 0.23% over the past day.
Sell
38
AXTI alert for Apr 8
AXT, Inc. [AXTI] is up 7.79% over the past day.
Buy
65
AEHR alert for Apr 8
Aehr Test Systems [AEHR] is down 2.97% over the past day.
